BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shin WJ, Seong BL. Novel antiviral drug discovery strategies to tackle drug-resistant mutants of influenza virus strains. Expert Opin Drug Discov 2019;14:153-68. [PMID: 30585088 DOI: 10.1080/17460441.2019.1560261] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Hou L, Zhang Y, Ju H, Cherukupalli S, Jia R, Zhang J, Huang B, Loregian A, Liu X, Zhan P. Contemporary medicinal chemistry strategies for the discovery and optimization of influenza inhibitors targeting vRNP constituent proteins. Acta Pharmaceutica Sinica B 2022;12:1805-24. [DOI: 10.1016/j.apsb.2021.11.018] [Reference Citation Analysis]
2 Kurskaya O, Prokopyeva E, Bi H, Sobolev I, Murashkina T, Shestopalov A, Wei L, Sharshov K. Anti-Influenza Activity of Medicinal Material Extracts from Qinghai–Tibet Plateau. Viruses 2022;14:360. [DOI: 10.3390/v14020360] [Reference Citation Analysis]
3 Everest H, Billington E, Daines R, Burman A, Iqbal M. The Emergence and Zoonotic Transmission of H10Nx Avian Influenza Virus Infections. mBio 2021;12:e0178521. [PMID: 34488450 DOI: 10.1128/mBio.01785-21] [Reference Citation Analysis]
4 Kim Y, Lee S, Kim Y, Jang IJ, Lee S. Pharmacokinetics and safety of a novel influenza treatment (baloxavir marboxil) in Korean subjects compared with Japanese subjects. Clin Transl Sci 2021. [PMID: 34664769 DOI: 10.1111/cts.13160] [Reference Citation Analysis]
5 Hossain MG, Akter S, Dhole P, Saha S, Kazi T, Majbauddin A, Islam MS. Analysis of the Genetic Diversity Associated With the Drug Resistance and Pathogenicity of Influenza A Virus Isolated in Bangladesh From 2002 to 2019. Front Microbiol 2021;12:735305. [PMID: 34603265 DOI: 10.3389/fmicb.2021.735305] [Reference Citation Analysis]
6 Takahashi JA, Barbosa BVR, Lima MTNS, Cardoso PG, Contigli C, Pimenta LPS. Antiviral fungal metabolites and some insights into their contribution to the current COVID-19 pandemic. Bioorg Med Chem 2021;46:116366. [PMID: 34438338 DOI: 10.1016/j.bmc.2021.116366] [Reference Citation Analysis]
7 Lee YN, Lee DH, Shin JI, Si YJ, Lee JH, Baek YG, Hong SY, Bunnary S, Tum S, Park M, Kye SJ, Lee MH, Lee YJ. Pathogenesis and genetic characteristics of a novel reassortant low pathogenic avian influenza A(H7N6) virus isolated in Cambodia in 2019. Transbound Emerg Dis 2021. [PMID: 34347386 DOI: 10.1111/tbed.14256] [Reference Citation Analysis]
8 Han B, He XH, Liu YQ, He G, Peng C, Li JL. Asymmetric organocatalysis: an enabling technology for medicinal chemistry. Chem Soc Rev 2021;50:1522-86. [PMID: 33496291 DOI: 10.1039/d0cs00196a] [Cited by in Crossref: 68] [Cited by in F6Publishing: 44] [Article Influence: 68.0] [Reference Citation Analysis]
9 Kausar S, Said Khan F, Ishaq Mujeeb Ur Rehman M, Akram M, Riaz M, Rasool G, Hamid Khan A, Saleem I, Shamim S, Malik A. A review: Mechanism of action of antiviral drugs. Int J Immunopathol Pharmacol 2021;35:20587384211002621. [PMID: 33726557 DOI: 10.1177/20587384211002621] [Cited by in F6Publishing: 23] [Reference Citation Analysis]
10 Ma Y, Frutos-Beltrán E, Kang D, Pannecouque C, De Clercq E, Menéndez-Arias L, Liu X, Zhan P. Medicinal chemistry strategies for discovering antivirals effective against drug-resistant viruses. Chem Soc Rev 2021;50:4514-40. [PMID: 33595031 DOI: 10.1039/d0cs01084g] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 11.0] [Reference Citation Analysis]
11 Fu Y, Jaarsma AH, Kuipers OP. Antiviral activities and applications of ribosomally synthesized and post-translationally modified peptides (RiPPs). Cell Mol Life Sci 2021;78:3921-40. [PMID: 33532865 DOI: 10.1007/s00018-021-03759-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Patel H, Kukol A. Integrating molecular modelling methods to advance influenza A virus drug discovery. Drug Discov Today 2021;26:503-10. [PMID: 33220433 DOI: 10.1016/j.drudis.2020.11.014] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Liu XH, Zhang X, Lu ZH, Zhu YS, Wang T. Potential molecular targets of nonstructural proteins for the development of antiviral drugs against SARS-CoV-2 infection. Biomed Pharmacother 2021;133:111035. [PMID: 33254013 DOI: 10.1016/j.biopha.2020.111035] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
14 Vazquez-pagan A, Honce R, Schultz-cherry S. Impact of influenza virus during pregnancy: from disease severity to vaccine efficacy. Future Virology 2020;15:441-53. [DOI: 10.2217/fvl-2020-0024] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Piasecka J, Lenartowicz E, Soszynska-Jozwiak M, Szutkowska B, Kierzek R, Kierzek E. RNA Secondary Structure Motifs of the Influenza A Virus as Targets for siRNA-Mediated RNA Interference. Mol Ther Nucleic Acids 2020;19:627-42. [PMID: 31945726 DOI: 10.1016/j.omtn.2019.12.018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
16 Tapia F, Laske T, Wasik MA, Rammhold M, Genzel Y, Reichl U. Production of Defective Interfering Particles of Influenza A Virus in Parallel Continuous Cultures at Two Residence Times-Insights From qPCR Measurements and Viral Dynamics Modeling. Front Bioeng Biotechnol 2019;7:275. [PMID: 31681751 DOI: 10.3389/fbioe.2019.00275] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
17 Honce R, Schultz-Cherry S. Impact of Obesity on Influenza A Virus Pathogenesis, Immune Response, and Evolution. Front Immunol. 2019;10:1071. [PMID: 31134099 DOI: 10.3389/fimmu.2019.01071] [Cited by in Crossref: 158] [Cited by in F6Publishing: 199] [Article Influence: 52.7] [Reference Citation Analysis]